The importance of neuroproteomic studies is that they will help elucidate the currently poorly understood biochemical mechanisms or pathways underlying various psychiatric, neurological and neurodegenerative diseases. In this chapter, we focus on traumatic brain injury (TBI), a neurological disorder currently with no FDA approved therapeutic treatment. This chapter describes data mining strategies for proteomic analysis in traumatic brain injury research so that the diagnosis and treatment of TBI can be developed. We should note that brain imaging provides only coarse resolutions and proteomic analysis yields much finer resolutions to these two problems. Our data mining approach is not only at the collected data level, but rather an integrated scheme of animal modeling, instrumentation and data analysis.
CITATION STYLE
Chen, S. S., Haskins, W. E., Ottens, A. K., Hayes, R. L., Denslow, N., & Wang, K. K. W. (2007). Bioinformatics for traumatic brain injury: Proteomic data mining. In Springer Optimization and Its Applications (Vol. 7, pp. 363–386). Springer International Publishing. https://doi.org/10.1007/978-0-387-69319-4_20
Mendeley helps you to discover research relevant for your work.